[Advances in biologic therapy for inflammatory bowel disease].
The medical management of inflammatory bowel disease has considerably changed thanks to the biologic agents coming. In this review a critical evaluation of controlled studies with biologic agents for the management of both Crohn's disease and ulcerative colitis is presented. The efficacy of these agents in moderate to severe ulcerative colitis and Crohn's disease has been one of the most important advances in the past decades.
Sostegni
Raffaello
R
Unità Operativa Autonoma Gastroenterologia, Azienda Ospedaliera Ordine Mauriziano, Torino.
Pera
Angelo
A
Daperno
Marco
M
Rocca
Rodolfo
R
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001691:Biological Therapy; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*
D000911:Antibodies, Monoclonal